Ristova 500 mg Injection ( Rituximab)

Manufacturer: Roche Products India Pvt Ltd

Medicine composition: Rituximab

Ristova 500Mg Injection acts as a monoclonal antibody. This drug is relatively new and is used to offer targeted therapy to treat cancer. Ristova 500Mg Injection only targets cancer cells in the body, thus the drug is less harmful as compared to Ristova 500Mg Injection radiation treatment.

Ristova 500Mg Injection is used to treat chronic lymphocytic leukemia and some types of non-hodgkin’s lymphoma.

The first dose of Ristova 500Mg Injection is given through an IV for about 6 hours. The time period of administering the dose may be reduced afterwards. Ristova 500Mg Injection is not available in the form of a tablet or pill. The dosage is determined by the doctor as per the patient’s health, age, weight, severity of the cancer and the body’s reaction to the drug.

You may or may not experience any related side effects of Ristova 500Mg Injection, such as fever accompanied with chills, nausea and vomiting, cough, headache, irritation of the throat and runny nose. If you do experience these side effects, do not be alarmed, just inform you doctor and he will provide medicine to control the symptoms.